Abstract
The SOCS family of genes are negative regulators of cytokine signalling with SOCS-1 displaying tumor suppressor activity. SOCS-1, CIS and SOCS-3 have been implicated in the regulation of red blood cell production. In this study, a detailed examination was conducted on the expression patterns of these three SOCS family members in normal erythroid progenitors and a panel of erythroleukemic cell lines. Unexpectedly, differences in SOCS gene expression were observed during maturation of normal red cell progenitors, viz changes to CIS were inversely related to the alterations of SOCS-1 and SOCS-3. Similarly, these SOCS genes were differentially expressed in transformed erythoid cells – erythroleukemic cells immortalized at an immature stage of differentiation expressed SOCS-1 and SOCS-3 mRNA constitutively, whereas in more mature cell lines SOCS-1 and CIS were induced only after exposure to erythropoietin (Epo). Significantly, when ectopic expression of the tyrosine kinase Lyn was used to promote differentiation of immature cell lines, constitutive expression of SOCS-1 and SOCS-3 was completely suppressed. Modulation of intracellular signalling via mutated Epo receptors in mature erythroleukemic lines also highlighted different responses by the three SOCS family members. Close scrutiny of SOCS-1 revealed that, despite large increases in mRNA levels, the activity of the promoter did not alter after erythropoietin stimulation; in addition, erythroid cells from SOCS-1−/− mice displayed increased sensitivity to Epo. These observations indicate complex, stage-specific regulation of SOCS genes during normal erythroid maturation and in erythroleukemic cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alexander WS, Starr R, Fenner JE, Scott CL, Handman E, Sprigg NS, Corbin JE, Cornish AL, Darwiche R, Owczarek CM, Kay TWH, Nicola NA, Hertzog PJ, Metcalf D and Hilton DJ . (1999). Cell, 98, 597–608.
Andrews NC, Erdjument-Bomage H, Davidson MB, Tempst P and Orkin SH . (1993). Nature, 362, 722–728.
Bieker JJ and Southwood CM . (1995). Mol. Cell. Biol., 15, 852–860.
Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C and Darnell Jr JE . (1999). Cell, 98, 295–303.
Brysha M, Zhang J, Bertolino P, Corbin J, Alexander W, Nicola N, Hilton D and Starr R . (2001). J. Biol. Chem., 276, 22086–22089.
Busfield SJ and Klinken SP . (1992). Blood, 80, 412–419.
Cacalano NA, Sanden D and Johnston JA . (2001). Nat. Cell Biol., 3, 460–465.
Chomczynski P and Sacchi N . (1987). Anal. Biochem., 162, 156–169.
Cohney SJ, Sanden D, Cacalano NA, Yoshimura A, Mui A, Migone TS and Johnston JA . (1999). Mol. Cel.l Biol., 19, 4980–4988.
Constantinescu SN, Ghaffari S and Lodish HF . (1999). Trends Endocrin. Metab., 10, 18–23.
Cooper MC, Levy J, Cantor LN, Marks PA and Rifkind RA . (1974). Proc. Natl. Acad. Sci. USA, 71, 1677–1680
Cory S, Maekawa T, McNeall J and Metcalf D . (1991). Cell Growth Differ., 2, 165–172.
Cull V, Tilbrook PA, Adenan AS, Chappell D, Ingley E, Sarna MK, Palmer TN, Watowich SS and Klinken SP . (2000). Oncogene, 19, 953–960.
D’Andrea AD, Yoshimura A, Yousoufian H, Zon LI, Koo J-W and Lodish HF . (1991). Mol. Cell. Biol., 11, 1980–1987.
De Jong MO, Wagemaker G and Wognum AW . (1995). Blood, 86, 4076–4085.
De Sepulveda P, Okkenhaug K, La Rose J, Hawley RG, Dubreuil P and Rottapel R . (1999). EMBO J., 18, 904–915.
Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawa H, Miyazaki T, Leonor N, Taniguchi T, Fujita T, Kanakura Y, Komiya S and Yoshimura A . (1997). Nature, 387, 921–924.
Gregorieff A, Pyronnet S, Sonenberg N and Veillette A . (2000). J. Biol. Chem., 275, 21596–21604.
Hawley RG, Lieu FHL, Fong AZC and Hawley TS . (1994). Gene Theraphy, 1, 136–138.
Hilton DJ, Richardson RT, Alexander WS, Viney EM, Willson TA, Sprigg NS, Starr R, Nicholson SE, Metcalf D and Nicola NA . (1998). Proc. Natl. Acad. Sci. USA, 95, 114–119.
Hodges V, Winter P and Lappin T . (1999). Br. J. Haematol., 106, 325–334.
Iacopetta BJ, Morgan EH and Yeoh GC . (1982). Biochim. Biophys. Acta, 687, 204–210.
Ihle JN . (1995). Nature, 377, 591–594.
Ikuta K, Kina T, McNeill I, Uchida N, Peault B, Chein Y and Weissman I . (1990). Cell, 62, 863–874.
Kamura T, Sato S, Haque D, Liu L, Kaelin Jr WG, Conaway RC and Conaway JW . (1998). Gene Dev., 12, 3872–3881.
Klingmuller U . (1997). Eur. J. Biochem., 249, 637–647.
Klingmuller U, Lorenz U, Cantley LC, Neel BG and Lodish HF . (1995). Cell, 80, 729–738.
Klinken SP and Nicola NA . (1990). Leukemia, 4, 24–28.
Klinken SP, Nicola NA and Johnson GR . (1988). Proc. Natl. Acad. Sci. USA, 85, 8506–8510.
Koury MJ and Bondurant MC . (1992). Eur. J. Biochem., 210, 649–663.
Lacronique V, Boureux A, Della Valle V, Poirel H, Tran Quang C, Mauchauffe M, Berthou C, Lessard M, Berger R, Ghysdael J and Bernard O . (1997). Science, 278, 1309–1312.
Landschulz KT, Noyes AN, Rogers O and Boyer SJ . (1989). Blood, 73, 1476–1486.
Marine J-C, McKay C, Wang D, Topham DJ, Parganas E, Nakajima H, Pendeville H, Yasukawa H, Sasaki A, Yoshimura A and Ihle JN . (1999). Cell, 98, 617–627.
Marshall CJ . (1988). J. Cell. Sci. Suppl., 10, 157–169.
Matsumoto A, Masuhara M, Mitsui K, Yokouchi M, Ohtsubo M, Misawa H, Miyajima A and Yoshimura A . (1997). Blood, 89, 3148–3154.
Metcalf D, Alexander WS, Elefanty AG, Nicola NA, Hilton DJ, Starr R, Mifsud S and Di Rago L . (1999). Leukemia, 13, 926–934.
Metz T, Harris AW and Adams JM . (1995). Cell, 82, 29–36.
Miller IJ and Bieker JJ . (1993). Mol. Cell. Biol., 13, 2776–2786.
Miura O, Nakamura N, Quelle FW, Witthuhn BA, Ihle JN and Aoki N . (1994). Blood, 84, 1501–1507
Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A, Nishimoto N, Kajita T, Taga T, Yoshizaki K, Akira S and Kishimoto T . (1997). Nature, 387, 924–929.
Ogawa M, Matsuzaki Y, Nishikawa S, Hayashi S, Kunisada T, Sudo T, Kina T, Nakauchi H and Nishikawa S . (1991). J. Exp. Med., 174, 63–71.
Ohya K, Kajigaya S, Yamashita Y, Miyazato A, Hatake K, Miura Y, Ikeda U, Shimada K, Ozawa K and Mano H . (1997). J. Biol. Chem., 272, 27178–27182.
Piechaczyk M, Blanchard J, Martin L, Dani C, Panabries F, El Sabrouty S and Jeanteur P . (1984). Nucleic Acids Res., 12, 6951–6963.
Pircher TJ, Geiger JN, Zhang DY, Miller CP, Gaines P and Wojchowski DM . (2001). J. Biol. Chem., 276, 8995–9002.
Rayner JR and Gonda TJ . (1994). Mol. Cell. Biol., 14, 880–887.
Roberts AW, Robb L, Rakar S, Hartley L, Cluse L, Nicola NA, Metcalf D, Hilton DJ and Alexander WS . (2001). Proc. Natl. Acad. Sci., 98, 9324–9329.
Rottapel R, Ilangumaran S, Neale C, La Rose J, Ho JM, Nguyen MH, Barber D, Dubreuil P and de Sepulveda P . (2002). Oncogene, 21, 4351–4362.
Saito H, Morita Y, Fujimoto M, Narazaki M, Naka T and Kishimoto T . (2000). J. Immunol., 164, 5833–5843.
Sasaki A, Yasukawa H, Shouda T, Kitamura T, Dikic I and Yoshimura A . (2000). J. Biol. Chem., 275, 29338–29347.
Schluter G, Boinska D and Nieman-Seyde SC . (2000). Biochem. Biophys. Res. Commun., 268, 255–261.
Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA and Hilton DJ . (1997). Nature, 387, 917–921.
Tilbrook PA, Bittorf T, Busfield SJ, Chappell D and Klinken SP . (1996a). J. Biol. Chem., 271, 3453–3459.
Tilbrook PA, Bittorf T, Callus B, Busfield SJ, Ingley E and Klinken SP . (1996b). Cell Growth Differ., 7, 511–520.
Tilbrook PA, Colley SM, McCarthy DJ, Marais R and Klinken SP . (2001a). Arch. Biochem. Biophys., 396, 128–132
Tilbrook PA, Ingley E, Williams JH, Hibbs ML and Klinken SP . (1997). EMBO J., 16, 1610–1619.
Tilbrook PA and Klinken SP . (1999). Growth Factors, 17, 25–35.
Tilbrook PA, Palmer GA, Bittorf T, McCarthy DJ, Wright MJ, Sarna MK, Linnekin D, Cull V, Williams JH, Ingley E, Schneider-Mergener J, Krystal G and Klinken SP . (2001b). Cancer Res., 61, 2453–2458.
Trowbridge IS, Lesley J and Schulte R . (1982). J. Cell Physiol., 112, 403–410.
Uoshima N, Ozawa M, Kimura S, Tanaka K, Wada K, Kobayashi Y and Kondo M . (1995). Brit. J. Haematol., 91, 30–36.
Vannucchi AM, Paoletti F, Linari S, Cellai C, Caporale R, Ferrini PR, Sanchez M, Migliaccio G and Migliaccio AR . (2000). Blood, 95, 2559–2568.
Verdier F, Chretien S, Muller O, Varlet P, Yoshimura A, Gisselbrecht S, Lacombe C and Mayeux P . (1998a). J. Biol. Chem., 273, 28185–28190.
Verdier F, Rabionet R, Gouilleux F, Beisenherzhuss C, Varlet P, Muller O, Mayeux P, Lacombe C, Gisselbrecht S and Chretien S . (1998b). Mol. Cell. Biol., 18, 5852–5860.
Waldmann V and Rabes HM . (1996). Pathol. Res. Prac., 192, 883–891.
Yoshikawa H, Matsubara K, Qian GS, Jackson P, Groopman JD, Manning JE, Harris CC and Herman JG . (2001). Nat. Genet., 28, 29–35.
Yoshimura A, Ohkubo T, Kiguchi T, Jenkins NA, Gilbert DJ, Copeland NG, Hara T and Miyajima A . (1995). EMBO J., 14, 2816–2826.
Zhang JG, Farley A, Nicholson SE, Willson TA, Zugaro LM, Simpson RJ, Moritz RL, Cary D, Richardson R, Hausmann G, Kile BJ, Kent SBH, Alexander WS, Metcalf D, Hilton DJ, Nicola NA and Baca M . (1999). Proc. Natl. Acad. Sci. USA, 96, 2071–2076.
Acknowledgements
We acknowledge the expert technical assistance from Shane Meakins, Research Centre, Royal Perth Hospital. Recombinant human Epo (Eprex) was a generous gift from Dr J Adams and Dr J Patava (Janssen-Cilag, Australia). This work was supported by grants from NHMRC (#99-0596 and the Block Grant to the Walter and Eliza Hall Institute), the Cancer Foundation of Western Australia, the Medical Research Foundation of Royal Perth Hospital, The Neurotrauma Research Program of Western Australia, the National Institutes of Health, Bethesda, Maryland (Grant CA-22556), National Cancer Institute and The National Institutes of Health, Bethesda, Maryland (Grant CA-77447). SJB is an NHMRC RD Wright Postdoctoral Fellow. RS was supported by a Postdoctoral Fellowship from the Australian Research Council.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sarna, M., Ingley, E., Busfield, S. et al. Differential regulation of SOCS genes in normal and transformed erythroid cells. Oncogene 22, 3221–3230 (2003). https://doi.org/10.1038/sj.onc.1206381
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206381
This article is cited by
-
MiR-124-3p/B4GALT1 axis plays an important role in SOCS3-regulated growth and chemo-sensitivity of CML
Journal of Hematology & Oncology (2016)
-
Division of labor by dual feedback regulators controls JAK2/STAT5 signaling over broad ligand range
Molecular Systems Biology (2011)
-
Loss of JAK2 regulation via a heterodimeric VHL-SOCS1 E3 ubiquitin ligase underlies Chuvash polycythemia
Nature Medicine (2011)
-
Lyn deficiency reduces GATA-1, EKLF and STAT5, and induces extramedullary stress erythropoiesis
Oncogene (2005)